Cargando…
Therapeutic ultrasound as a potential male contraceptive: power, frequency and temperature required to deplete rat testes of meiotic cells and epididymides of sperm determined using a commercially available system
BACKGROUND: Studies published in the 1970s by Mostafa S. Fahim and colleagues showed that a short treatment with ultrasound caused the depletion of germ cells and infertility. The goal of the current study was to determine if a commercially available therapeutic ultrasound generator and transducer c...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340307/ https://www.ncbi.nlm.nih.gov/pubmed/22289508 http://dx.doi.org/10.1186/1477-7827-10-7 |
_version_ | 1782231444164182016 |
---|---|
author | Tsuruta, James K Dayton, Paul A Gallippi, Caterina M O'Rand, Michael G Streicker, Michael A Gessner, Ryan C Gregory, Thomas S Silva, Erick JR Hamil, Katherine G Moser, Glenda J Sokal, David C |
author_facet | Tsuruta, James K Dayton, Paul A Gallippi, Caterina M O'Rand, Michael G Streicker, Michael A Gessner, Ryan C Gregory, Thomas S Silva, Erick JR Hamil, Katherine G Moser, Glenda J Sokal, David C |
author_sort | Tsuruta, James K |
collection | PubMed |
description | BACKGROUND: Studies published in the 1970s by Mostafa S. Fahim and colleagues showed that a short treatment with ultrasound caused the depletion of germ cells and infertility. The goal of the current study was to determine if a commercially available therapeutic ultrasound generator and transducer could be used as the basis for a male contraceptive. METHODS: Sprague-Dawley rats were anesthetized and their testes were treated with 1 MHz or 3 MHz ultrasound while varying power, duration and temperature of treatment. RESULTS: We found that 3 MHz ultrasound delivered with 2.2 Watt per square cm power for fifteen minutes was necessary to deplete spermatocytes and spermatids from the testis and that this treatment significantly reduced epididymal sperm reserves. 3 MHz ultrasound treatment reduced total epididymal sperm count 10-fold lower than the wet-heat control and decreased motile sperm counts 1,000-fold lower than wet-heat alone. The current treatment regimen provided nominally more energy to the treatment chamber than Fahim's originally reported conditions of 1 MHz ultrasound delivered at 1 Watt per square cm for ten minutes. However, the true spatial average intensity, effective radiating area and power output of the transducers used by Fahim were not reported, making a direct comparison impossible. We found that germ cell depletion was most uniform and effective when we rotated the therapeutic transducer to mitigate non-uniformity of the beam field. The lowest sperm count was achieved when the coupling medium (3% saline) was held at 37 degrees C and two consecutive 15-minute treatments of 3 MHz ultrasound at 2.2 Watt per square cm were separated by 2 days. CONCLUSIONS: The non-invasive nature of ultrasound and its efficacy in reducing sperm count make therapeutic ultrasound a promising candidate for a male contraceptive. However, further studies must be conducted to confirm its efficacy in providing a contraceptive effect, to test the result of repeated use, to verify that the contraceptive effect is reversible and to demonstrate that there are no detrimental, long-term effects from using ultrasound as a method of male contraception. |
format | Online Article Text |
id | pubmed-3340307 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-33403072012-05-01 Therapeutic ultrasound as a potential male contraceptive: power, frequency and temperature required to deplete rat testes of meiotic cells and epididymides of sperm determined using a commercially available system Tsuruta, James K Dayton, Paul A Gallippi, Caterina M O'Rand, Michael G Streicker, Michael A Gessner, Ryan C Gregory, Thomas S Silva, Erick JR Hamil, Katherine G Moser, Glenda J Sokal, David C Reprod Biol Endocrinol Research BACKGROUND: Studies published in the 1970s by Mostafa S. Fahim and colleagues showed that a short treatment with ultrasound caused the depletion of germ cells and infertility. The goal of the current study was to determine if a commercially available therapeutic ultrasound generator and transducer could be used as the basis for a male contraceptive. METHODS: Sprague-Dawley rats were anesthetized and their testes were treated with 1 MHz or 3 MHz ultrasound while varying power, duration and temperature of treatment. RESULTS: We found that 3 MHz ultrasound delivered with 2.2 Watt per square cm power for fifteen minutes was necessary to deplete spermatocytes and spermatids from the testis and that this treatment significantly reduced epididymal sperm reserves. 3 MHz ultrasound treatment reduced total epididymal sperm count 10-fold lower than the wet-heat control and decreased motile sperm counts 1,000-fold lower than wet-heat alone. The current treatment regimen provided nominally more energy to the treatment chamber than Fahim's originally reported conditions of 1 MHz ultrasound delivered at 1 Watt per square cm for ten minutes. However, the true spatial average intensity, effective radiating area and power output of the transducers used by Fahim were not reported, making a direct comparison impossible. We found that germ cell depletion was most uniform and effective when we rotated the therapeutic transducer to mitigate non-uniformity of the beam field. The lowest sperm count was achieved when the coupling medium (3% saline) was held at 37 degrees C and two consecutive 15-minute treatments of 3 MHz ultrasound at 2.2 Watt per square cm were separated by 2 days. CONCLUSIONS: The non-invasive nature of ultrasound and its efficacy in reducing sperm count make therapeutic ultrasound a promising candidate for a male contraceptive. However, further studies must be conducted to confirm its efficacy in providing a contraceptive effect, to test the result of repeated use, to verify that the contraceptive effect is reversible and to demonstrate that there are no detrimental, long-term effects from using ultrasound as a method of male contraception. BioMed Central 2012-01-30 /pmc/articles/PMC3340307/ /pubmed/22289508 http://dx.doi.org/10.1186/1477-7827-10-7 Text en Copyright ©2012 Tsuruta et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Tsuruta, James K Dayton, Paul A Gallippi, Caterina M O'Rand, Michael G Streicker, Michael A Gessner, Ryan C Gregory, Thomas S Silva, Erick JR Hamil, Katherine G Moser, Glenda J Sokal, David C Therapeutic ultrasound as a potential male contraceptive: power, frequency and temperature required to deplete rat testes of meiotic cells and epididymides of sperm determined using a commercially available system |
title | Therapeutic ultrasound as a potential male contraceptive: power, frequency and temperature required to deplete rat testes of meiotic cells and epididymides of sperm determined using a commercially available system |
title_full | Therapeutic ultrasound as a potential male contraceptive: power, frequency and temperature required to deplete rat testes of meiotic cells and epididymides of sperm determined using a commercially available system |
title_fullStr | Therapeutic ultrasound as a potential male contraceptive: power, frequency and temperature required to deplete rat testes of meiotic cells and epididymides of sperm determined using a commercially available system |
title_full_unstemmed | Therapeutic ultrasound as a potential male contraceptive: power, frequency and temperature required to deplete rat testes of meiotic cells and epididymides of sperm determined using a commercially available system |
title_short | Therapeutic ultrasound as a potential male contraceptive: power, frequency and temperature required to deplete rat testes of meiotic cells and epididymides of sperm determined using a commercially available system |
title_sort | therapeutic ultrasound as a potential male contraceptive: power, frequency and temperature required to deplete rat testes of meiotic cells and epididymides of sperm determined using a commercially available system |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340307/ https://www.ncbi.nlm.nih.gov/pubmed/22289508 http://dx.doi.org/10.1186/1477-7827-10-7 |
work_keys_str_mv | AT tsurutajamesk therapeuticultrasoundasapotentialmalecontraceptivepowerfrequencyandtemperaturerequiredtodepleterattestesofmeioticcellsandepididymidesofspermdeterminedusingacommerciallyavailablesystem AT daytonpaula therapeuticultrasoundasapotentialmalecontraceptivepowerfrequencyandtemperaturerequiredtodepleterattestesofmeioticcellsandepididymidesofspermdeterminedusingacommerciallyavailablesystem AT gallippicaterinam therapeuticultrasoundasapotentialmalecontraceptivepowerfrequencyandtemperaturerequiredtodepleterattestesofmeioticcellsandepididymidesofspermdeterminedusingacommerciallyavailablesystem AT orandmichaelg therapeuticultrasoundasapotentialmalecontraceptivepowerfrequencyandtemperaturerequiredtodepleterattestesofmeioticcellsandepididymidesofspermdeterminedusingacommerciallyavailablesystem AT streickermichaela therapeuticultrasoundasapotentialmalecontraceptivepowerfrequencyandtemperaturerequiredtodepleterattestesofmeioticcellsandepididymidesofspermdeterminedusingacommerciallyavailablesystem AT gessnerryanc therapeuticultrasoundasapotentialmalecontraceptivepowerfrequencyandtemperaturerequiredtodepleterattestesofmeioticcellsandepididymidesofspermdeterminedusingacommerciallyavailablesystem AT gregorythomass therapeuticultrasoundasapotentialmalecontraceptivepowerfrequencyandtemperaturerequiredtodepleterattestesofmeioticcellsandepididymidesofspermdeterminedusingacommerciallyavailablesystem AT silvaerickjr therapeuticultrasoundasapotentialmalecontraceptivepowerfrequencyandtemperaturerequiredtodepleterattestesofmeioticcellsandepididymidesofspermdeterminedusingacommerciallyavailablesystem AT hamilkatherineg therapeuticultrasoundasapotentialmalecontraceptivepowerfrequencyandtemperaturerequiredtodepleterattestesofmeioticcellsandepididymidesofspermdeterminedusingacommerciallyavailablesystem AT moserglendaj therapeuticultrasoundasapotentialmalecontraceptivepowerfrequencyandtemperaturerequiredtodepleterattestesofmeioticcellsandepididymidesofspermdeterminedusingacommerciallyavailablesystem AT sokaldavidc therapeuticultrasoundasapotentialmalecontraceptivepowerfrequencyandtemperaturerequiredtodepleterattestesofmeioticcellsandepididymidesofspermdeterminedusingacommerciallyavailablesystem |